Quantitative analysis of arachidonic acid, endocannabinoids, N-acylethanolamines and steroids in biological samples by LCMS/MS: Fit to purpose

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1012-1013, Issue , 2016, Pages 215-221

  Gachet, M Salomé ^a   Gertsch, Jürg ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Arachidonic acid; Biological samples; Correlation; Cortisol; Eicosanoids; Quantitation; Tandem mass spectrometry; Validation

Indexed keywords

ARACHIDONIC ACID; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE; N ACYLETHANOLAMINE; PROSTANOID; STEROID; UNCLASSIFIED DRUG; N-ACYLETHANOLAMINES;

BODY FLUID; HUMAN; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLITE; NONHUMAN; NOTE; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS; BLOOD; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MALE; MASS FRAGMENTOGRAPHY; PROCEDURES; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

ARACHIDONIC ACID; CHROMATOGRAPHY, LIQUID; ENDOCANNABINOIDS; ETHANOLAMINES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIMIT OF DETECTION; MALE; REPRODUCIBILITY OF RESULTS; STEROIDS; TANDEM MASS SPECTROMETRY;

EID: 85002381705     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2015.11.013     Document Type: Note

References (30)

1. Fan, Y.Y., Monk, J.M., Hou, T.Y., Callway, E., Vincent, L., Weeks, B., et al. Characterization of an arachidonic acid-deficient (Fads1 knockout) mouse model. J. Lipid Res. 53 (2012), 1287–1295.
2. Stroud, C.K., Nara, T.Y., Roqueta-Rivera, M., Radlowski, E.C., Lawrence, P., Zhang, Y., et al. Disruption of FADS2 gene in mice impairs male reproduction and causes dermal and intestinal ulceration. J. Lipid Res. 50 (2009), 1870–1880.
3. Alexander, S.P., Kendall, D.A., The complications of promiscuity: endocannabinoid action and metabolism. Br. J. Pharmacol. 152 (2007), 602–623.
4. Di Marzo, V., De Petrocellis, L., Why do cannabinoid receptors have more than one endogenous ligand?. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367 (2012), 3216–3228.
5. Alhouayek, M., Masquelier, J., Muccioli, G.G., Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy. Drug Discov. Today 19 (2014), 295–304.
6. Zoerner, A.A., Gutzki, F.-M., Batkai, S., May, M., Rakers, C., Engeli, S., et al. Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective. Biochim. Biophys. Acta 1811 (2011), 706–723.
7. Gachet, M.S., Rhyn, P., Bosch, O.G., Quednow, B.B., Gertsch, J., A quantitiative LC–MS/MS method for the measurement of arachidonic acid, prostanoids, endocannabinoids, N-acylethanolamines and steroids in human plasma. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 976–977 (2015), 6–18.
8. Montuschi, P., Santini, G., Valente, S., Mondino, C., Macagno, F., Cattani, P., Zini, G., Mores, N., Liquid chromatography–mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases. J. Chromatogr. B Analyt. Technol. Biomed Life Sci. 964 (2014), 12–25.
9. Montuschi, P., LC/MS/MS analysis of leukotriene B4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation. J. Chromatogr. B Analyt. Technol. Biomed Life Sci. 877 (2009), 1272–1280.
10. Tsikas, D., Zoerner, A.A., Analysis of eicosanoids by LC–MS/MS and GC?MS/MS: a historical retrospect and a discussion. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 964 (2014), 79–88.
11. Carvalho, V.M., The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 883–884 (2012), 50–58.
12. van den Ouweland, J.M., Kema, I.P., The role of liquid chromatography–tandem mass spectrometry in the clinical laboratory. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 883–884 (2012), 18–32.
13. Vogeser, M., Seger, C., Pitfalls associated with the use of liquid chromatography–tandem mass spectrometry in the clinical laboratory. Clin. Chem. 56 (2010), 1234–1244.
14. Tsikas, D., Quantitative analysis of eicosanoids in biological samples by LC–MS/MS: mission accomplished?. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2015, 10.1016/j.jchromb.2015.04.018 (in press).
15. Schweer, H., Kammer, J., Seyberth, H.W., Simultaneous determination of prostanoids in plasma by gas chromatography-negative-ion chemical-ionization mass spectrometry. J.Chromatogr. 338 (1985), 273–280.
16. Shinde, D.D., Kim, K.-B., Oh, K.-S., Abdalla, N., Liu, K.-H., Bae, S.K., et al. LC–MS/MS for the simultaneous analysis of arachidonic acid and 32 related metabolites in human plasma: basal plasma concentrations and aspirin-induced changes of eicosanoids. J. Chromatogr. B. Analyt. Technol. Biomed Life Sci. 911 (2012), 113–121.
17. Cao, H., Xiao, L., Park, G., Wang, X., Azim, A.C., Christman, J.W., van Breemen, R.B., An improved LC–MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluid. Anal. Biochem. 372 (2008), 41–51.
18. Psychogios, N., Hau, D.D., Peng, J., Guo, A.C., Mandal, R., Bouatra, S., et al. The human serum metabolome. PLoS One, 6, 2011, e16957.
19. Quehenberger, O., Armando, A.M., Brown, A.H., Milne, S.B., Myers, D.S., et al. Lipidomics reveals a remarkable diversity of lipids inhuman plasma. J. Lipid Res. 51 (2010), 3299–3305.
20. Zoerner, A.A., Gutzki, F.M., Suchy, M.T., Beckmann, B., Engeli, S., Jordan, J., Tsikas, D., Targeted stable-isotope dilution GC–MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 877 (2009), 2909–2923.
21. Balvers, M.G.J., Verhoeckx, K.C.M., Witkamp, R.F., Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 877 (2009), 1583–1590.
22. Amoako, A.A., Marczylo, T.H., Lam, P.M., Willets, J.M., Derry, A., Elson, J., Konje, J.C., Quantitative analysis of anandamide and related acylethanolamides in human seminal plasma by ultra-performance liquid chromatography tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878 (2010), 3231–3237.
23. Rozet, E., Ceccato, A., Hubert, C., Ziemons, E., Oprean, R., Rudaz, S., Boulanger, B., Hubert, P., Analysis of recent pharmaceutical regulatory documents on analytical method validation. J. Chromatogr. A 1158 (2007), 111–125.
24. Tsikas, D., A proposal for comparing methods of quantitative analysis of endogenous compounds in biological systems by using the relative lower limit of quantification (rLLOQ). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 (2009), 2244–2251.
25. Kalsbeek, A., Fliers, E., Daily regulation of hormone profiles. Handb. Exp. Pharmacol. 217 (2013), 185–226.
26. Fukami, A., Adachi, H., Hirai, Y., Enomoto, M., Otsuka, M., Kumagai, E., et al. Association of serum eicosapentaenoic acid to arachidonic acid ratio with microalbuminuria in a population of community-dwelling Japanese. Atherosclerosis 239 (2015), 577–582.
27. Hauer, D., Schelling, G., Gola, H., Campolongo, P., Morath, J., Roozendaal, B., et al. Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder. PLoS One, 8, 2013, e62741.
28. Mattace Raso, G., Russo, R., Calignano, A., Meli, R., Palmitoylethanolamide in CNS health and disease. Pharmacol. Res. 86 (2014), 32–41.
29. Long, J.Z., Li, W., Booker, L., Burston, J.J., Kinsey, S.G., Schlosburg, J.E., et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat. Chem. Biol. 5 (2009), 37–44.
30. Bosch, O.G., Eisenegger, C., Gertsch, J., von Rotz, R., Dornbierer, D., Gachet, M.S., et al. Gammahydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone. Psychoneuroendocrinology 17 (2015), 1–10.